ImmunoGen Reports Recent Progress and First Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall Street rallies as Fed's Waller eases rate hike fears
- Fed’s Waller open to September rate hold - if disinflation holds up
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Nvidia to acquire AI platform Hugging Face in landmark $12.9B deal
- Tesla to unveil Cybercab Texas today, details are few
Immunogen (IMGN) Misses Q1 EPS by 2c, Maintains FY Guidance
May 1, 2020 6:35 AM EDTImmunogen (NASDAQ: IMGN) reported Q1 EPS of ($0.17), $0.02 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $13.3 million versus the consensus estimate of $14.94 million.
GUIDANCE:
Immunogen sees Q2 2020 revenue of $60-65 million, versus the consensus of $62.72... More
